Navigation Links
John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden
Date:8/1/2009

NEW YORK, July 29 /PRNewswire/ -- Grammy-Award winning artist and long-time (PRODUCT)RED supporter John Legend is joining with Gap to create an exclusive (RED)ZONE seating section for his August 13th, 2009 concert at Madison Square Garden in New York City. Beginning July 29th, every purchase at select Gap stores in the New York tri-state area will include a special access code enabling shoppers to obtain one ticket in the reserved RED(ZONE) section for John Legend's MSG show. Even better, with each (RED)ZONE ticket purchase, shoppers will automatically receive a second ticket to the show free of charge. Additionally, a select number of fans seated in the (RED)ZONE section will be randomly selected to go backstage to personally meet Legend after the evening's performance. Proceeds from the ticket sales in the (RED)ZONE will benefit HIV/AIDS programs in Africa supported by the Global Fund.

"I love working with (PRODUCT)RED because they provide an innovative way for great brands and great artists to come together to powerfully and effectively fight AIDS in Africa," said Legend. "I'm proud to be partnering with Gap and (RED)(TM) on my upcoming Madison Square Garden concert, because I know the money generated will go directly to help get medicine to those who need it."

Tickets to this exclusive (RED)ZONE area are available by visiting www.johnlegend.com/red and entering the special access code as prompted - tickets are $66.00 each and are subject to limited availability. Fans can log on to www.gap.com/johnlegend to locate participating Gap stores in the New York tri-state area.

Gap is celebrating its collaboration with John Legend and the launch of the new (PRODUCT)RED Artist Edition T-shirts by turning Gap store windows (RED) nationwide from July 29 through August 12. Gap also opened a special pop-up art gallery adjacent to its Fifth Avenue flagship store in New York City on Saturday, July 25th. The shop features Gap (PRODUCT)RED Artist Edition T-Shirts, as well as original works of art from some of these artists. Fifty percent of the profits all Gap (PRODUCT)RED Artist Edition T-Shirts benefit the Global Fund to help eliminate AIDS in Africa.

About John Legend's Show Me Campaign

Grammy Award winner, John Legend founded the Show Me Campaign after visiting Millennium Villages in Ghana and Tanzania. The non-profit's mission is to end poverty around the world through sustainable development at the individual, family and small community levels. Go to http://www.showmecampaign.org/ for more information.

About Gap Inc.

Gap Inc. is a leading global specialty retailer offering clothing, accessories and personal care products for men, women, children and babies under the Gap, Banana Republic, Old Navy, Piperlime and Athleta brand names. Fiscal 2008 sales were $14.5 billion. Gap Inc. operates more than 3,100 stores in the United States, the United Kingdom, Canada, France, Japan and Ireland. In addition, Gap Inc. is expanding its international presence with franchise agreements in Asia, Europe, Latin America and the Middle East. For more information, please visit gapinc.com.

About (RED)(TM) and (PRODUCT)RED(TM)

(RED)'s primary objective is to engage the private sector in raising awareness and funds for the Global Fund, to help eliminate AIDS in Africa. Companies whose products take on the (PRODUCT)RED mark contribute a significant percentage of the sales or portion of the profits from that product to the Global Fund to finance AIDS programs in Africa, with an emphasis on the health of women and children. Current partners are: American Express (U.K. only), Apple, Converse, Gap, Emporio Armani, Hallmark, Dell, Windows and Starbucks. Since its launch in the Spring of 2006, more than $130 million has been generated by (RED) for the Global Fund. (RED) money is at work in Swaziland, Rwanda, Ghana and Lesotho. For more information, visit http://www.joinred.com/

About The Global Fund to Fight AIDS, Tuberculosis and Malaria

Since its creation in 2002, the Global Fund has become the dominant financer of programs to fight AIDS, tuberculosis and malaria, with approved funding of US $15 billion for programs in 140 countries. The Global Fund supports programs based on agreed performance targets and disburses money in response to proven results. At the end of 2008, programs supported by the Global Fund have averted more than 3.5 million deaths by providing AIDS treatment for 2 million people, TB treatment for 4.6 million people, and by the distribution of 70 million insecticide-treated bed nets for the prevention of malaria worldwide. For more information visit http://www.theglobalfund.org.


'/>"/>
SOURCE Gap Inc.; (RED)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test
2. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
3. GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip
4. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
5. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
6. Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa
7. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
8. Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa
9. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
10. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
11. Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):